Loading...
Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours
BACKGROUND: Most gastrointestinal stromal tumours (GIST) are driven by activating oncogenic mutations of KIT/PDGFRA, which provide a compelling therapeutic target. Our previous studies showed that CDC37, regulated by casein kinase 2 (CK2), is a crucial HSP90 cofactor for KIT oncogenic function and a...
Na minha lista:
| Udgivet i: | Br J Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group UK
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7000686/ https://ncbi.nlm.nih.gov/pubmed/31776458 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0657-5 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|